Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
Completed · Phase 2
Conditions studied: Head and Neck Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin plus gemcitabine in treating patients with advanced squamous cell head and neck cancer that cannot be treated by surgery or radiation therapy.
Key facts
- Study ID
- NCT00003264
- Run by
- Fox Chase Cancer Center
- People needed
- 22
- Starts
- 1997-10-01
- Expected to finish
- 2002-06-01
- Last updated by the study team
- 2013-04-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hunterdon Regional Cancer Center — Flemington, New Jersey, United States
- Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County — Mount Holly, New Jersey, United States
- Riverview Medical Center - Booker Cancer Center — Red Bank, New Jersey, United States
- St. Francis Medical Center — Trenton, New Jersey, United States
- St. Luke's Network - Bethlehem — Bethlehem, Pennsylvania, United States
- Delaware County Memorial Hospital — Drexel Hill, Pennsylvania, United States
- Harrisburg Polyclinic Medical Center — Harrisburg, Pennsylvania, United States
- Saint Mary Regional Center — Langhorne, Pennsylvania, United States
- North Penn Hospital — Lansdale, Pennsylvania, United States
- Paoli Memorial Hospital — Paoli, Pennsylvania, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- Reading Hospital and Medical Center — Reading, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.